|
About Us
KGK Synergize Inc. (KGK) is a biotechnology company that specializes
in nutraceutical and functional food research and development. The company
operates two divisions: a fast growing contract research organization
(CRO) for third parties 2) an in-house nutraceutical product development
(NPD) division. KGK Synergize is ISO 9001:2000 registered and GLP
certified.
The CRO division offers a wide range of research services to the client
from pre-clinical to clinical trials, data analysis and consultation. KGK
can assist the client with protocol development and direct them as to the
most beneficial studies to help them meet their objectives.
The NPD division experiments with new and unique natural compounds for
their therapeutic values. It implements various screening techniques to
develop nutraceutical and functional food products to the point where they
are ready to manufacture and market. KGK is the innovator of SytrinolTM,
a novel ingredient for cholesterol. Other products next to market include
DiabetinolTM, for the prevention and treatment of type II
diabetes, and DermytolTM, geared to those consumers worried
about melanoma and the damaging effects of the sun on their skin.
Contract Research Services
cell screening (anti-cancer, anti-diabetic,
cholesterol lowering activities)
in vivo models (cardiovascular, diabetes, cancer,
inflammation)
Toxicity models (acute, chronic, maximum tolerated dose)
Human clinical trials (menopause, arthritis, weight loss,
cardiovascular, diabetes)
www.kgksynergize.com
|
